MedTrace Logo

Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells

NCT00801333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-03-05

No results posted yet for this study

Summary

Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.

The major goal of the project is to develop human iPS cells from various types of cell cultures or lines from existing collections. The IPS cells will be developed for modeling diseases, for developing the technology that may eventually allow the use of IPS cells for transplantation therapy, and for basic research.

Conditions

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Benjamin E Reubinoff, MD PhD · Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801333 on ClinicalTrials.gov